[Course of the manifestations associated with the antiprothrombinase circulating anticoagulant].
Fifteen patients (9 females and 6 males) with the "lupus type" circulating anticoagulant have been studied. The underlying disease was an auto-immune disorder in 11 cases and a malignant hemopathy in 4 cases. The manifestations frequently associated with the lupus inhibitor, such as thrombosis, thrombocytopenia and false-positive VDRL test were analysed. Hemorrhagic syndrome occurred only when thrombocytopenia or acquired abnormality of Willebrand's factor was present. Thrombotic events (8 cases) were frequent. Deep venous thrombosis was complicated with pulmonary embolism in 4 patients. Platelet abnormality, decreased fibrinolytic response or acquired Willebrand's syndrome were found in all patients with a thrombotic event. These different manifestations followed diverging courses in some patients with persistent thrombocytopenia although the anticoagulant had disappeared in 3 cases, negativation of the false-positive VDRL test while the anticoagulant remained unchanged in 1 case, occurrence of a thromboembolic episode although the anticoagulant had disappeared in 1 case.
D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology; D005165:Factor V / Q000276:immunology*; D005170:Factor X / Q000276:immunology*; D015951:Factor Xa; D005260:Female; D006402:Hematologic Diseases / Q000276:immunology; D006487:Hemostasis; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology; D013921:Thrombocytopenia / Q000276:immunology*; D013927:Thrombosis / Q000276:immunology*; D013997:Time Factors
D001323:Autoantibodies; D007136:Immunoglobulins; D010743:Phospholipids; C019158:circulating anticoagulants; C022475:prothrombinase complex; D005165:Factor V; D005170:Factor X; D015951:Factor Xa
Evolution des manifestations associées à l'anticoagulant circulant antiprothrombinase.